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fatty liver disease in postmenopausal women
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Abstract
Resting heart rate, a simple and useful indicator of autonomic function, and its imbalance has emerged as an independent predictor
of cardio metabolic diseases. Nonalcoholic fatty liver disease (NAFLD) is increasingly being diagnosed worldwide and is strongly
associated with the features of cardiometabolic diseases. This study aimed to examine the association between resting heart rate
and NAFLD in postmenopausal women.
The cross-sectional study included 1017 postmenopausal women aged ≥46 years, who attended a health examination program.
Resting heart rate and NAFLDweremeasured in all subjects who underwent amedical examination. Resting heart rate quartiles were
categorized as follows: Q1: 56 to 65, Q2: 66 to 71, Q3: 72 to 78, and Q4: 79 to 99beats/min. The odds ratios and 95% confidence
intervals for NAFLD were calculated after adjusting for confounding variables across resting heart rate quartiles using multiple logistic
regression analysis.
The prevalence of NAFLD increased with increasing resting heart rate quartiles: 28.2% for Q1, 31.5% for Q2, 33.4% for Q3, and
38.1% for Q4 (P< .001). Compared to the 1st quartile, the odds ratio (95% confidence intervals) of NAFLD in the 4th quartile of resting
heart rates was 2.11 (1.17–3.42) after adjusting for age, body mass index, cigarette smoking, regular exercise, blood pressure, total
cholesterol, triglyceride, aspartate aminotransferase, and alanine aminotransferase levels.
Resting heart rate was positively associated with NAFLD in postmenopausal women, suggesting that it could be a useful additional
measure to assess the risk for NAFLD in postmenopausal women.
Abbreviations: ANS = autonomic nervous system, BMI = body mass index, HDL = high density lipoprotein, NAFLD =
nonalcoholic fatty liver disease.
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1. Introduction
Nonalcoholic fatty liver disease (NAFLD) is characterized by a
diffuse accumulation of triglycerides within hepatocytes and
excludes excessive alcohol intake and other causes of liver
disease. The prevalence of NAFLD has increased globally in
recent decades, and NAFLD is the most common form of chronic
liver disease worldwide, affecting 20% to 30% of the general
population.[1,2] In postmenopausal women, a significant decrease
in estrogen leads to weight gain and redistribution of body fat,
including visceral fat accumulation,[3–5] which stimulates an
influx of free fatty acids into the liver and hepatic steatosis. Thus,
NAFLD is more prevalent in postmenopausal women than in
premenopausal women.[6]
Resting heart rate, a global index of vital signs is a simple, cost-
effective, and useful indicator of the status of the autonomic
nervous system (ANS). A higher resting heart rate represents an
imbalance in ANS activity, reflecting an increased sympathetic and
decreased parasympathetic tone.[7–9] A growing amount of
evidence indicates that a higher resting heart rate, even within
the normal range, is an independent predictor of cardiovascular
disease and metabolic syndrome.[8–13] Numerous cross-sectional
and prospective studies have explored the association between
increased sympathetic activity or decreased parasympathetic
activity and cardiometabolic disease.[8–12]Therefore, an imbalance
of theANSactivitymaybe involved in thepathogenesisofNAFLD.
However, it remains unclear whether a higher ratio of
sympathetic to parasympathetic activity, manifested by a higher
resting heart rate, is associated with NAFLD. Therefore, the
purpose of the study was to examine the relationship between
resting heart rate and NAFLD in postmenopausal women.
2. Methods
2.1. Study participants
We retrospectively reviewed the medical records of 1,315
postmenopausalwomen aged≥46 yearswho underwent amedical
examination at the Health Promotion Center of Gangnam
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Severance Hospital in Seoul, Korea, betweenNovember 2011 and
July 2013. Natural menopause was defined as the final menstrual
period and diagnosedwhen awomanhadmissed her period for 12
consecutive months. We excluded participants who met at least 1
of the following criteria: a history of exogenous estrogen or
tamoxifen therapy; a history of induced menopause such as
bilateral oophorectomy, radiation- or drug-inducedmenopause; a
history of ischemic heart disease, arrhythmia, thyroid, respiratory,
renal, hepatobiliary, or rheumatologic disease; subjects with an
alcohol intake of 70g/wk or more, a positive test for hepatitis B
antigens or hepatitis C antibodies, hepatic enzyme higher than 2
times the upper limit of the reference range, resting heart rate55
or≥100beats/min; leukocyte count≥10,000cells/m/l;missing data
or not fasting for 12-h before testing. Following exclusion criteria,
a total of 1,017 participants were included for the final analysis.
The participants voluntarily visited the health promotion center
regularly to undergo a health examination. Informed consent was
obtained from each participant. This study was conducted in
accordance with the ethical principles of the Declaration of
Helsinki andapprovedby the InstitutionalReviewBoardofYonsei
University College of Medicine, Seoul, Korea.
2.2. Data collection
Each participant completed a self-report questionnaire regarding
lifestyle and medical history to determine cigarette smoking
status, alcohol consumption, and physical activity. Participants
were categorized as non-smokers (people who had never smoked
or smoked less than 100 cigarettes in their lifetime), ex-smokers
(people who had smoked ≥100 cigarettes in their lifetime but did
not smoke in the present), and current smokers (people who had
smoked ≥100 cigarettes and smoked daily or occasionally in the
present). Participants were asked about the type and frequency of
leisure-time weekly physical activity levels. Regular exercise was
defined as moderate or vigorous-intensity aerobic exercise
activity for at least 30 minutes on ≥ 3days/week. Body weight
and height were measured to the nearest 0.1kg and 0.1cm,
respectively, in light indoor clothing without shoes. Body mass
index (BMI) was calculated as the weight in kilograms divided by
the square of the height in meters (kg/m2). Participants’ resting
heart rate was recorded during the baseline examination, using an
automatic blood pressure monitor (FT-500, Jawon Medical Co.
Ltd.). The automatic blood pressure monitor measured the
frequency of the heartbeat and time duration while measuring the
blood pressure, and the heart beats per minute were calculated.
Systolic blood pressure and diastolic blood pressure were
measured twice in the right arm using a standard mercury
sphygmomanometer (Baumanometer, Copiague, NY). All blood
samples were obtained from the antecubital vein after a 12-hour
overnight fast. Fasting plasma glucose, total cholesterol,
triglycerides, high-density lipoprotein (HDL) cholesterol, aspar-
tate aminotransferase, alanine aminotransferase, g-glutamyl
transferase, alkaline phosphatase, and uric acid levels were
measured through enzymatic methods using a Hitachi 7600 to
110 automated chemistry analyzer (Hitachi), and leukocyte
counts were quantified using an automated blood cell counter
(ADVIA 120, Bayer, NY).
Due to the large sample size and the ethical limitations for the
routine use of liver biopsy in apparently healthy subjects, the
diagnosis of fatty liver was based on abdominal ultrasonography
with a 3.5-MHz transducer (HDI 5000, Philips, Bothell, WA).
Ultrasonography was performed by 2 experienced radiologists
who were unaware of the aims of the study and blinded to
laboratory findings. The coefficients of variation for inter- and
intra-operator reproducibility were 6.8% and 4.3%, respectively.
The presence of hepatic steatosis was determined according to the
findings of high hepatorenal echo contrast, bright liver, or
attenuation of ultrasound in a deep area of the liver. Hepatic
steatosis was graded according to the criteria described
previously[14,15]: Mild, slight diffuse increase in bright homoge-
nous echoes in liver parenchyma, with normal visualization of the
diaphragm and portal and hepatic vein borders, and normal
hepatorenal contrast; moderate, diffuse increase in bright echoes
in liver parenchyma, with slightly impaired visualization of the
peripheral portal and hepatic vein borders; and severe, marked
increase in bright echoes at a shallow depth, with deep
attenuation and impaired visualization of the diaphragm and
marked vascular blurring. Liver with any degree of hepatic
steatosis was considered NAFLD in the present study.
The modified National Cholesterol Education Program Adult
Treatment Panel III definition of metabolic syndrome was used.
As the waist circumference was not measured, we defined obesity
as a BMI ≥25kg/m2, as suggested in the position statement of the
American College of Endocrinology.[16] Metabolic syndrome
was defined as the presence of 3 or more of the following risk
factors: obesity with BMI ≥ 25.0kg/m2; elevated systolic blood
pressure ≥ 130mm Hg or diastolic blood pressure ≥ 85mm Hg,
or the use of anti-hypertensive medication; high fasting plasma
glucose ≥ 100mg/dL or the use of anti-diabetic medication; high
triglyceride ≥ 150mg/dL and low HDL cholesterol <50mg/dL.
2.3. Statistical analysis
Resting heart rate was categorized into quartiles as follows: Q1:
56 to 65, Q2: 66 to 71, Q3: 72 to 78, and Q4: 79 to 99beats/min.
The clinical characteristics of the study population according to
resting heart rate quartiles were compared using 1-way analysis
of variance or the Kruskal-Wallis test for continuous variables
according to the normality of distributions and chi-square test for
categorical variables. Normal distribution was evaluated with the
determination of skewness using the Kolmogorov-Smirnov test.
Continuous data are presented as mean (standard deviation) or
median (interquartile range), and categorical data are presented
as frequencies. The odds ratios and 95% confidence intervals for
NAFLD were calculated after adjusting for confounding
variables across resting heart rate quartiles using multiple logistic
regression analysis. All analyses were conducted using SAS
statistical software (version 9.4; SAS Institute Inc., Cary, NC). All
statistical tests were two-sided, and statistical significance was
determined at P< .05.
3. Results
Table 1 shows the clinical and biochemical characteristics of the
study population according to resting heart rate quartiles. The
mean values for BMI, blood pressure, fasting plasma glucose,
total cholesterol, leukocyte counts, and the median triglyceride
levels were highest in the 4th quartile of resting heart rate. The
proportion of regular exercise decreased, whereas metabolic
syndrome increased in accordance with resting heart rate
quartiles.
Figure 1 shows the prevalence of NAFLD according to resting
heart rate quartiles. The overall prevalence of NAFLD was
33.9% and increased with increasing resting heart rate quartiles:
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28.2% for Q1, 31.5% for Q2, 33.4% for Q3, and 38.1% for Q4
(P< .001).
Table 2 shows the results of multiple logistic regression
analysis to assess the odds of predicting the presence of NAFLD
in terms of resting heart rate quartiles. Compared to the referent
1st quartile, the odds ratio (95% confidence intervals) of NAFLD
in the 4th quartile of resting heart rate was 2.11 (1.17–3.42) after
adjusting for age, BMI, cigarette smoking, regular exercise, blood
Figure 1. Prevalence of nonalcoholic fatty liver disease (NAFLD) according to resting heart rate quartiles in postmenopausal women (P value was calculated by
analysis of variance (ANOVA) test).
Table 1
Clinical and biochemical characteristics of the study population according to resting heart rate quartiles
∗
.
Resting heart rate quartiles (beats/min)
Total Q1 (56–65) Q2 (66–71) Q3 (73–78) Q4 (79–99) P- value
n 1017 249 277 241 250
Age, yr 57.7 (6.8) 57.6 (6.8) 57.5 (6.6) 57.4 (6.6) 57.8 (6.7) .177
BMI (kg/m2) 23.5 (3.0) 23.3 (3.3) 23.5 (2.9) 23.6 (2.8) 23.8 (3.0) .002
Systolic blood pressure (mm Hg) 124.9 (16.8) 121.0 (16.7) 124.2 (15.8) 124.8 (16.8) 129.4 (17.0) <.001
Diastolic blood pressure (mm Hg) 77.0 (10.1) 73.6 (9.5) 76.7 (9.5) 77.4 (10.1) 80.2 (10.1) <.001
Fasting plasma glucose (mg/dL) 96.2 (18.6) 92.5 (14.2) 94.5 (18.3) 95.7 (15.0) 101.9 (23.0) <.001
Total cholesterol (mg/dL) 203.1 (35.5) 199.2 (34.4) 203.1 (34.4) 204.8 (36.7) 205.0 (36.2) .002
Triglyceride (mg/dL) 103 (75–139) 99 (74–147) 100 (77–140) 101 (75–155) 112 (76–155) .015
HDL-cholesterol (mg/dL) 55.5 (12.8) 55.9 (13.5) 54.9 (12.2) 55.5 (12.6) 55.6 (13.0) .430
AST, U/L 21 (18–24) 20 (18–24) 21 (18–24) 20 (18–24) 21 (18–24) .107
ALT, U/L 17 (14–23) 17 (14–23) 18 (14–24) 17 (14–22) 18 (14–22) .291
GGT, U/L 17 (13–25) 17 (!3–24) 17 (13–26) 16 (13–23) 18 (1426) .196
ALP, U/L 62 (52–76) 59 (52–71) 62 (51–78) 63 (52–75) 65 (53–79) .002
Uric acid (mg/dL) 4.3 (0.9) 4.3 (0.9) 4.3 (0.9) 4.2 (1.0) 4.2 (1.0) .451
Leukocyte, cells/mL 5680 (1462) 5411 (1372) 5641 (1491) 5693 (1383) 5949 (1349) <.001
Current smoking† (%) 2.8 3.1 2.7 3.6 1.7 .117
Regular exercise‡ (%) 41.4 47.8 47.1 38.5 31.9 <.001
Metabolic syndromex (%) 29.5 26.8 27.1 30.0 33.9 .003
ALP= alkaline phosphatase, ALT= alanine aminotransferase, AST=aspartate aminotransferase, BMI=body mass index, HDL=high density lipoprotein. Data are expressed as the mean (SD), median
(interquartile range, IQR), or percentage.
∗
P values were calculated using 1-way ANOVA test, Kruskal Wallis test, or chi-square test.
† Alcohol drinking ≥twice/wk.
‡ Regular exercise ≥3 times/wk.
xMetabolic syndrome was defined by the presence of three or more of the following risk factors: obesity with BMI ≥25.0 kg/m2, elevated systolic blood pressure ≥130 mm Hg, elevated diastolic blood pressure
≥85 mm Hg, or a current use of hypertension medication, and high fasting plasma glucose ≥ 100mg/dL or a current use of diabetes medication, high triglycerides ≥150mg/dL, low HDL cholesterol<50mg/dL.
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pressure, total cholesterol, triglyceride, aspartate aminotransfer-
ase, and alanine aminotransferase levels. We also assessed the
association between resting heart rate and NAFLD after
additionally adjusting for alkaline phosphatase level and
leukocyte count. These positive associations were similar using
model 3.
4. Discussion
In this cross-sectional study, a higher resting heart rate was
independently and positively associated with NAFLD in
postmenopausal women after adjusting for potential confound-
ing variables. We believe that this is the first study to evaluate the
association between resting heart rate and NAFLD. Some
mechanisms could explain the significant relationships between
resting heart rate and NAFLD. The current understanding of the
development and progression of NAFLD involves the “2-hit
hypothesis.”[17,18] The “first hit” means insulin resistance
associated with visceral obesity, which leads to high levels of
circulating free fatty acids and excess fat accumulation in
hepatocytes, resulting in fatty liver. The subsequent onset of
oxidative stress acts as a “second hit” and results in hepatocyte
injury, inflammation, and fibrosis. The liver damage may be
modulated by additional insults, such as excessive free fatty acids
in hepatocytes and other triggering factors.
A higher resting heart rate represents sympathetic overactivity
and parasympathetic underactivity. Adrenergic stimulation and
hypothalamic-pituitary-adrenal axis activation accompanied by
sympathetic activation can contribute to insulin resistance.
Moreover, sympathetic activation appears to play a synergistic
causal role in obesity-associated insulin resistance through
bidirectional interactions. Increased heart rate has been associat-
ed with obesity, cardiovascular disease, and metabolic syndrome
in cross-sectional and longitudinal studies.[19–24] In a meta-
analysis with seven longitudinal and ten cross-sectional studies,
Lui et al determined that the pooled risk ratio of metabolic
syndromewas 2.10 for the highest resting heart rate versus lowest
resting heart rate and a 28% risk increase per 10beats/min
increment in resting heart rate.[25] In the present study, resting
heart rate was also positively associated with metabolic
syndrome and its components, other than HDL-cholesterol.
Thus, a higher resting heart rate could be closely related to the
“first hit” hypothesis. Reactive oxidative stress and low-grade
inflammation could explain the significant relationship between
resting heart rate and NAFLD, as suggested in the “second hit”
hypothesis. A higher resting heart rate may reflect a higher rate of
oxygen consumption and metabolic rate, leading to increased
oxidative stress and elevation of pro-inflammatory cytokines,
such as interleukin-6 and tumor necrosis factor-a.[26] This
inflammatory cascade may inhibit insulin secretion in pancreatic
b-cells and promote insulin resistance in the liver.[27] In the
present study, leukocyte count gradually increased with the
resting heart rate quartiles, which is in agreement with the
previous results showing positive associations between resting
heart rate and elevated inflammatory marker.[28,29]
Some limitations should be considered in the interpretation of
this study. First, it had a cross-sectional design, suggesting that
caution should be used in causal-effect interpretations. Future
prospective research is warranted to elucidate the temporal
relationship between resting heart rate and NAFLD. Second, we
lacked information on insulin resistance, such as homeostasis
model assessment of insulin resistance, and thus no direct
relationship between resting heart rate and insulin sensitivity was
demonstrated. Third, we did not take into consideration the effect
of other potential confounding variables such as waist circum-
ference, low-density lipoprotein cholesterol, HbA1C, C-reactive
protein, and urine microalbumin. These variables were not fully
adjusted for in the statistical model, causing a possible residual
confounding effect. Fourth, we did not take into consideration
the effect of medications, such as b-blockers, calcium channel
blockers, and selective serotonin reuptake inhibitors on resting
heart rate. Fifth, important confounders such as anemia, diabetes,
hypertension, chronic kidney disease, and sleep-disordered
breathing were missing in our study. Sixth, transient elastog-
raphy, an easy and non-invasive method to identify NAFLD was
not used. Transient elastography combined with ultrasonogra-
phy could increase the positive predictive value for significant
fibrosis compared to ultrasonography alone.[30] Lastly, although
liver biopsy is the gold standard for the diagnosis of fatty liver,
biopsy-proven NAFLD was not assessed in the present study.
Liver biopsy is an invasive procedure dictated by the clinical
setting, while ultrasonography is a non-invasive and widely
available method for qualitative assessments of hepatic fat
accumulation. Thus, ultrasonography is the preferred modality
for mass screening for hepatic steatosis with reasonable accuracy
(67%–94%).[31]
5. Conclusion
In the current study, resting heart rate was significantly associated
withNAFLD in postmenopausal women, suggesting resting heart
rate in postmenopausal women could be a useful additional
measure in assessing the prevalence risk of NAFLD. Our findings
support the hypothesis that a higher ratio of sympathetic to
parasympathetic activity may be involved in the parthenogenesis
of NAFLD.
Table 2
Odds ratios and 95% confidence for nonalcoholic liver disease according to resting heart rate quartiles.
Resting heart rate quartiles (rate/min)
Q1 (56–65) Q2 (66–71) Q3 (73–78) Q4 (79–99) P for trend
Model 1a 1.00 1.27 (0.83–1.96) 1.44 (0.96–2.19) 2.30 (1.48–3.48) <.001
Model 2b 1.00 1.30 (0.80–2.22) 1.33 (0.83–2.17) 2.11 (1.17–3.42) .004
Model 3c 1.00 1.29 (0.78–2.16) 1.30 (0.82–2.16) 1.98 (1.19–3.29) .009
Model 1: Adjusted for age and BMI.
Model 2: Adjusted for age, BMI, cigarette smoking, regular exercise, blood pressure, total cholesterol, triglyceride, AST, and ALT level.
Model 2: Adjusted for age, BMI, cigarette smoking, regular exercise, blood pressure, total cholesterol, triglyceride, AST, ALT, ALP levels, and leukocyte count.
ALP=alkaline phosphatase, ALT = alanine aminotransferase, AST = aspartate aminotransferase, BMI = body mass index.
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